Page last updated: 2024-11-04

ropinirole and Supranuclear Palsy, Progressive

ropinirole has been researched along with Supranuclear Palsy, Progressive in 2 studies

Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manolakis, AC1
Kardasi, M1
Tsiopoulos, FD1
Kapsoritakis, AN1
Psychos, AK1
Potamianos, SP1

Reviews

1 review available for ropinirole and Supranuclear Palsy, Progressive

ArticleYear
[Parkinson disease: diagnostic and therapeutic criteria].
    Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8

    Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis,

2001

Other Studies

1 other study available for ropinirole and Supranuclear Palsy, Progressive

ArticleYear
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) with fatal outcome, after the manifestation of an ampullary adenocarcinoma.
    Pancreas, 2010, Volume: 39, Issue:5

    Topics: Adenocarcinoma; Aged; Amantadine; Ampulla of Vater; Antiparkinson Agents; Common Bile Duct Neoplasms

2010